Searchable abstracts of presentations at key conferences in endocrinology

ea0081p337 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Roux-en-Y gastric bypass and vertical sleeve gastrectomy showed similar efficacy in achieving cardiometabolic composite target in subject with type 2 diabetes undergoing bariatric surgery

Monte Lavinia , Tuccinardi Dario , Rossini Giovanni , Watanabe Mikiko , Pozzilli Paolo , Napoli Nicola , Manfrini Silvia

Introduction: The American Diabetes Association (ADA) produced a triple composite outcome that summarizes the therapeutic targets of the three most prevalent complications of obesity: type 2 diabetes (T2D), hypertension and dyslipidemia (HbA1c <7.0%; LDL cholesterol<100 mg/dl and systolic blood pressure <130 mmHg). The present study primarily investigates the difference between VSG and RYGB in achieving the composite target one year after the surgery. The secondary...

ea0021p294 | Pituitary | SFEBES2009

Can we ever stop imaging in surgically treated and radiotherapy naive patients with non-functioning pituitary adenoma?

Gubbihal Raghava Reddy , Karavitaki Niki , Parvizi Nassim , Sangha Vicky , Watanabe Mikiko , Cudlip Simon , Wass John A H

Background: Non-functioning pituitary adenomas (NFAs) are slow growing tumours with reported 5-year recurrence rates following resection up to 51%. The time point that it is safe to stop surveillance imaging is not clearly defined.Aim: To clarify the time spectrum of recurrence in patients with NFAs offered solely surgery as primary treatment and to estimate the safe time to stop surveillance pituitary imaging.Methods: Case-note an...

ea0081p342 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

IGF1-zSDS in patients suffering from obesity with or without metabolic syndrome: a cross-sectional study in 2032 subject

Masi Davide , Risi Renata , Tozzi Rossella , Gangitano Elena , Curreli Mariaignazia , Watanabe Mikiko , Mariani Stefania , Gnessi Lucio , Lubrano Carla

Background: Metabolic syndrome (MS) is associated with increased mortality, and the key factors predictive of its development among patients with obesity are still unclear. We recently demonstrated with a machine learning approach that Insulin-like Growth Factor 1 (IGF-1) is a novel marker of metabolic health and that in individuals with obesity, lower IGF-1 levels are associated with increased metabolic deterioration. However, the interpretation of IGF-1 serum measurement is ...

ea0099p114 | Pituitary and Neuroendocrinology | ECE2024

Obesity-Related pseudo-cushing syndrome and pituitary incidentaloma: a case study

Strinati Vittoria , Veroi Gabriele , Masi Davide , Nevi Paola , Ventimiglia Valentina , Watanabe Mikiko , Mariani Stefania , Gnessi Lucio , Lubrano Carla

Introduction: The diagnosis of Cushing’s syndrome (CS) can be challenging for endocrinologists due to its multifaceted presentation. Accurate differentiation between Pseudo-Cushing syndrome (PCS) and true CS is crucial as their treatment approaches and outcomes vary significantly.Case Report: A 43-year-old male patient with grade III obesity (BMI: 49.9 kg/m2) presented to our Endocrinology outpatient clinic with a complex medical history ...

ea0081p103 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

The crosstalk between adiposity and bone: a potential role for SIRT1 and sclerostin

Tozzi Rossella , Masi Davide , Cipriani Fiammetta , Elena Spoltore Maria , Contini Savina , Watanabe Mikiko , Basciani Sabrina , Lubrano Carla , Gnessi Lucio , Mariani Stefania

Background and aim: Sirtuin1 (SIRT1) and sclerostin play important roles in adipose tissue and bone metabolism. SIRT1 pharmacological induction improves bone quality both in murine and human models and- as adiposity increases – its expression decreases both in peripheral tissues and blood. Sclerostin reduces osteoblasts’ differentiation and mineralization and is associated with DMT2, obesity and cardiovascular risk. We evaluated the circulating SIRT1 and sclerostin r...

ea0081p142 | Pituitary and Neuroendocrinology | ECE2022

Chondrosarcoma of the cavernous sinus treated with postoperative proton radiation therapy: case report and endocrinological follow up after 36 months

Masi Davide , risi renata , balena angela , caputi alessandra , elena spoltore maria , rossetti rebecca , watanabe mikiko , Tozzi Rossella , Gangitano Elena , mariani stefania , Lenzi Andrea , gnessi lucio , lubrano carla

Case Summary: In May 2018, a 22-year-old man was admitted to the Emergency Room of Polyclinic Umberto I Hospital of Rome, because of progressive headaches and binocular diplopia. Brain MRI revealed a heterogeneous T1WI-hypointense and T2WI-hyperintense mass of 40x28x25 mm (CC, LL, AP) including calcification areas in the left paramedian region of the clivus invading the homolateral cavernous sinus. The patient underwent partial tumour resection via infratemporal approach and a...

ea0099p511 | Pituitary and Neuroendocrinology | ECE2024

Assessment of GH/IGF1 axis in relation to pituitary volume and MRI intensity in subjects with obesity: A controlled, cross-sectional, observational study

Veroi Gabriele , De Alcubierre Dario , Masi Davide , Rossetti Rebecca , Elena Spoltore Maria , Gangitano Elena , Watanabe Mikiko , Mariani Stefania , Gnessi Lucio , Lubrano Carla

Background: It has been reported that some Magnetic Resonance Imaging (MRI) pituitary findings may reflect specific endocrinological alterations, as in the case of adult-onset growth hormone deficiency (GHD), which has already been associated with lower MRI-derived pituitary height and volume in pediatric patients.Purpose: The objective of this study was to investigate potential associations between pituitary morphology and signal intensity on MRI with G...

ea0099ep259 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

A ketogenic diet as feasible treatment for post bariatric weight regain

Cipriani Fiammetta , chiara Massari Maria , Letizia Spizzichini Maria , Masi Davide , Ernesti Ilaria , Genco Alfredo , Migliaccio Silvia , Mariani Stefania , Gnessi Lucio , Lubrano Carla , Watanabe Mikiko

Introduction: Metabolic surgery is the most effective long-term treatment for obesity. However, studies reveal that up to 40% of post-bariatric subjects experience long-term weight regain (WR), particularly those who discontinue surgical and nutritional follow-ups. In contrast, the ketogenic diet emerges as a pivotal therapy for obesity, showing convincing evidence in weight loss and improvement of weight-related complications.Purpose: This study aims to...

ea0099ep662 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Eating behavior patterns, metabolic parameters, and circulating levels of oxytocin in patientswith obesity: a prospective pilot study

Maria Baldazzi Giorgia , Masi Davide , Massetti Chandra , Letizia Spizzichini Maria , Cipriani Fiammetta , Colonnello Elena , Ignazia Curreli Maria , Watanabe Mikiko , Mariani Stefania , Gnessi Lucio , Lubrano Carla

Introduction: Obesity is a chronic disease, significantly influenced by maladaptive eating patterns. Oxytocin (OT), recognized for its central role in regulating energy metabolism and eating behavior, represents a potential link in understanding this intricate relationship.Objective: This study aimed to investigate the potential association between circulating levels of OT and maladaptive eating behaviors, assessed through the Eating Behaviors Assessment...

ea0081ep358 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Reduction in Oxytocin levels predict body weight loss in patients with obesity after a very low carbohydrate ketogenic diet (VLCKD).

Tozzi Rossella , Basciani Sabrina , Rossetti Rebecca , Balena Angela , Masi Davide , Risi Renata , Veroi Gabriele , Colonnello Elena , Chiara Massari Maria , Curreli Mariaignazia , Gangitano Elena , Watanabe Mikiko , Mariani Stefania , Gnessi Lucio , Lubrabno Carla

Background: Oxytocin (OXT) enhances glucose uptake and lipid utilization in adipose tissue and skeletal muscle.Dysfunction of the OXT system could underlie the pathogenesis of weight gain. Men and women with obesity were reported to have higher OXT blood levels compared to normal weight subjects. In contrast, metabolic syndrome has been associated with reduced fasting serum oxytocin in larger scale mixed gender studies.Aim: Data regarding the oxytocin sy...